에서 이용할 수 있어요!
자세히 알아보기
Humacyte Inc Warrant
HUMAW
HUMAW
상장폐지됨
HUMAW 종목은 2026년 8월 25일에 상장 폐지됐어요.
소개: Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
직원 수: 184
뉴스
긍정적
중립
부정적
투자 심리
3개월
긍정적
0%
중립
0%
부정적
0%
가격 차트는 Lightweight Charts™ 라이브러리로 구현했어요